Latest Medical statistics Stories

2014-06-16 12:29:16

Aspire IRB and Midlands IRB become part of the WCG family, further expanding its geographic and program reach PRINCETON, N.J., June 16, 2014 /PRNewswire/ -- The WIRB-Copernicus Group

2014-06-16 08:29:45

PHILADELPHIA, June 16, 2014 /PRNewswire/ -- TransCelerate BioPharma Inc.

2014-06-04 08:30:14

SANTA ROSA, Calif., June 4, 2014 /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN), a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics

2014-06-04 04:21:45

VIENNA, June 4, 2014 /PRNewswire/ -- AFFiRiS announced today the results of a phase II study in Alzheimer patients. AFFiRiS' proprietary compound AD04 is the first drug

2014-06-02 12:29:04

Results of CISCRP Study Provide New Insights Into How to Engage the Public and Patients PRINCETON, N.J., June 2, 2014 /PRNewswire/ -- inVentiv Clinical Trial Recruitment

2014-05-27 08:27:36

SYDNEY and BEDMINSTER, N.J., May 27, 2014 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug Administration (FDA) has

2014-05-22 08:31:11

SAN FRANCISCO, May 22, 2014 /PRNewswire/ -- PULSE enables highly customized IRT trial design while maintaining endpoint's signature 30-Day delivery timeline

2014-05-19 08:28:29

SAN FRANCISCO, May 19, 2014 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR), a biopharmaceutical company developing novel pain and cancer therapeutics, announced that Ivan Gergel, M.D., will

2014-05-15 23:14:53

Collaboration Will Ensure Local Monitoring and Centralized Clinical Research Technology for Sponsors of Multinational Clinical Trials Irvine, CA (PRWEB) May

2014-05-13 23:08:34

Major Pharmaceutical Companies Serving in ADDPLAN DF Consortium Providing Early Feedback Dublin, Ireland (PRWEB) May 13, 2014 ICON plc (NASDAQ: ICLR),

Word of the Day
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.